Article info
Correspondence
Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’
- Correspondence to Professor Guixiu Shi; gshi{at}xmu.edu.cn; Professor Yuan Liu; liuyuan{at}xmu.edu.cn
Citation
Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’
Publication history
- Received December 7, 2020
- Accepted December 8, 2020
- First published January 27, 2021.
Online issue publication
February 10, 2023
Article Versions
- Previous version (27 January 2021).
- Previous version (7 October 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.